These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 649515)
1. A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. I. Isolation and characterization of a pentose-excreting auxotrophic mutant of Nocardia mediterranei with drastically reduced rifamycin production. Ghisalba O; Nüesch J J Antibiot (Tokyo); 1978 Mar; 31(3):202-14. PubMed ID: 649515 [TBL] [Abstract][Full Text] [Related]
2. A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. II. Isolation and characterization of a shikimate excreting auxotrophic mutant of Nocardia mediterranei with normal rifamycin-production. Ghisalba O; Nüesch J J Antibiot (Tokyo); 1978 Mar; 31(3):215-25. PubMed ID: 649516 [TBL] [Abstract][Full Text] [Related]
3. A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. III. Isolation and identification of an early aromatic ansamycin-precursor containing the seven-carbon amino starter-unit and three initial acetate/propionate-units of the ansa chain. Ghisalba O; Fuhrer H; Richter WJ; Moss S J Antibiot (Tokyo); 1981 Jan; 34(1):58-63. PubMed ID: 7251510 [TBL] [Abstract][Full Text] [Related]
4. A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. IV. Identification of 3-amino-5-hydroxybenzoic acid as a direct precursor of the seven-carbon amino starter-unit. Ghisalba O; Nüesch J J Antibiot (Tokyo); 1981 Jan; 34(1):64-71. PubMed ID: 7251511 [TBL] [Abstract][Full Text] [Related]
5. New rifamycins produced by a recombinant strain of Nocardia mediterranei. Schupp T; Traxler P; Auden JA J Antibiot (Tokyo); 1981 Aug; 34(8):965-70. PubMed ID: 7319929 [TBL] [Abstract][Full Text] [Related]
6. Ansamycin biogenesis: studies on a novel rifamycin isolated from a mutant strain of Nocardia mediterranei. White RJ; Martinelli E; Lancini G Proc Natl Acad Sci U S A; 1974 Aug; 71(8):3260-4. PubMed ID: 4528428 [TBL] [Abstract][Full Text] [Related]
7. A genetic approach to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. V. Studies on the biogenetic origin of 3-substituents. Traxler P; Ghisalba O J Antibiot (Tokyo); 1982 Oct; 35(10):1361-6. PubMed ID: 7174520 [No Abstract] [Full Text] [Related]
8. Study to the biosynthesis of the rifamycin-chromophore in Nocardia mediterranei. Gygax D; Ghisalba O; Treichler H; Nüesch J J Antibiot (Tokyo); 1990 Mar; 43(3):324-6. PubMed ID: 2324014 [No Abstract] [Full Text] [Related]
9. [Effect of low molecular weight regulators on the biosynthesis of rifamycin B by Amycolatopsis mediterranei strains]. Bushueva OA; Efremenkova OV; Gorin SE; Bartoshevich IuE Antibiot Khimioter; 1991 Mar; 36(3):11-5. PubMed ID: 1877868 [TBL] [Abstract][Full Text] [Related]
10. Early intermediates in the biosynthesis of ansamycins. I. Isolation and identification of protorifamycin I. Ghisalba O; Traxler P; Nüesch J J Antibiot (Tokyo); 1978 Nov; 31(11):1124-31. PubMed ID: 721708 [TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of mycelium morphological characteristics and rifamycin B production using Nocardia mediterranei. Lee KJ; Rho YT J Biotechnol; 1994 Aug; 36(3):239-45. PubMed ID: 7765266 [TBL] [Abstract][Full Text] [Related]
12. Improvement of industry-applied rifamycin B-producing strain, Amycolatopsis mediterranei, by rational screening. Jin ZH; Lin JP; Xu ZN; Cen PL J Gen Appl Microbiol; 2002 Dec; 48(6):329-34. PubMed ID: 12682871 [TBL] [Abstract][Full Text] [Related]
13. Effect of B-factor and its analogues on rifamycin biosynthesis in Nocardia sp. Kawaguchi T; Azuma M; Horinouchi S; Beppu T J Antibiot (Tokyo); 1988 Mar; 41(3):360-5. PubMed ID: 3366694 [TBL] [Abstract][Full Text] [Related]
15. [Regulatory effects of terminal products and intermediates of aromatic pathways on rifamycin biosynthesis in Nocardia mediterranei]. Gu WL; Xia TH; Jiao RS Wei Sheng Wu Xue Bao; 1988 Mar; 28(1):56-61. PubMed ID: 2898835 [No Abstract] [Full Text] [Related]
16. Thiazorifamycins. III. Biosynthesis of rifamycins P, Q and verde, novel metabolites from a mutant of Nocardia mediterranea. Cricchio R; Antonini P; Sartori G J Antibiot (Tokyo); 1980 Aug; 33(8):842-6. PubMed ID: 7429988 [TBL] [Abstract][Full Text] [Related]
17. Rifamycin G, a further product of Nocardia mediterranei metabolism. Lancini G; Sartori G J Antibiot (Tokyo); 1976 Apr; 29(4):466-8. PubMed ID: 931815 [No Abstract] [Full Text] [Related]
18. 16,17-dihdrorifamycin S and 16,17-dihydro-17-hydroxyrifamycin S. Two novel rifamycins from a recombinant strain C 5/42 of Nocardia mediterranei. Traxler P; Schupp T; Wehrli W J Antibiot (Tokyo); 1982 May; 35(5):594-601. PubMed ID: 7107523 [No Abstract] [Full Text] [Related]
19. Solid state fermentation and production of rifamycin SV using Amycolatopsis mediterranei. Nagavalli M; Ponamgi SP; Girijashankar V; Venkateswar Rao L Lett Appl Microbiol; 2015 Jan; 60(1):44-51. PubMed ID: 25256628 [TBL] [Abstract][Full Text] [Related]
20. [Method for developing a controlled process. Study of the possible regulation of rifamycin B biosynthesis]. Kuz'mina LM; Krasnova TP; Lysko AV; Vostrikova VN; Rychkov AE; Kolesnikova NA; Mal'tsev NI Antibiot Khimioter; 1990 Jul; 35(7):5-8. PubMed ID: 2285341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]